< Back to Article

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis

Figure 1

Study flow chart.

The figure presents the numbers of participants who were randomly assigned, received pioglitazone or placebo, and were analysed for the primary outcome.

doi: https://doi.org/10.1371/journal.pone.0037885.g001